‘Guided Missile’ Cancer Immunotherapy Boosted by €62M Funding

11:57 EDT 13 May 2019 |

The Swiss-Italian biotech company Philogen has raised a private round of €62M to fund the phase III development of cancer immunotherapies that deliver immune cell-stimulating molecules directly to the tumor site. The money will push Philogen’s two lead cancer programs, currently in phase III, to the market. The funds will also help to expand the […]

The post ‘Guided Missile’ Cancer Immunotherapy Boosted by €62M Funding appeared first on

Original Article: ‘Guided Missile’ Cancer Immunotherapy Boosted by €62M Funding


More From BioPortfolio on "‘Guided Missile’ Cancer Immunotherapy Boosted by €62M Funding"

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...